Display options
Cite
Zhang J, Kim JD, Beaver HA, et al. Rhino-orbital Mucormycosis Treated Successfully with Posaconazole without Exenteration. Neuroophthalmology. 2013;37(5):198-203doi: 10.3109/01658107.2013.809463.
Zhang, J., Kim, J. D., Beaver, H. A., Takashima, M., & Lee, A. G. (2013). Rhino-orbital Mucormycosis Treated Successfully with Posaconazole without Exenteration. Neuro-ophthalmology (Aeolus Press), 37(5), 198-203. https://doi.org/10.3109/01658107.2013.809463
Zhang, Jason, et al. "Rhino-orbital Mucormycosis Treated Successfully with Posaconazole without Exenteration." Neuro-ophthalmology (Aeolus Press) vol. 37,5 (2013): 198-203. doi: https://doi.org/10.3109/01658107.2013.809463
Zhang J, Kim JD, Beaver HA, Takashima M, Lee AG. Rhino-orbital Mucormycosis Treated Successfully with Posaconazole without Exenteration. Neuroophthalmology. 2013 Sep 24;37(5):198-203. doi: 10.3109/01658107.2013.809463. eCollection 2013. PMID: 28167988; PMCID: PMC5291008.
Copy Download .nbib Format: NLM
Share it on

Neuroophthalmology. 2013 Sep 24;37(5):198-203. doi: 10.3109/01658107.2013.809463. eCollection 2013.

Rhino-orbital Mucormycosis Treated Successfully with Posaconazole without Exenteration.

Neuro-ophthalmology (Aeolus Press)

Jason Zhang, James D Kim, Hilary A Beaver, Masayoshi Takashima, Andrew G Lee

Affiliations

  1. Department of Ophthalmology, The Methodist Hospital, HoustonTexasUSA; Baylor College of Medicine, HoustonTexasUSA.
  2. Department of Ophthalmology, The Methodist Hospital, HoustonTexasUSA; Department of Ophthalmology, The University of Texas Medical Branch, GalvestonTexasUSA.
  3. Department of Ophthalmology, The Methodist Hospital, Houston Texas USA.
  4. Baylor College of Medicine, Houston Texas USA.
  5. Department of Ophthalmology, The Methodist Hospital, HoustonTexasUSA; Baylor College of Medicine, HoustonTexasUSA; Departments of Ophthalmology, Neurology, and Neurosurgery, Weill Cornell Medical College, New YorkNew YorkUSA; Department of Ophthalmology, The University of Texas Medical Branch, GalvestonTexasUSA; Department of Ophthalmology, The University of Iowa Hospitals and Clinics, Iowa CityIowaUSA.

PMID: 28167988 PMCID: PMC5291008 DOI: 10.3109/01658107.2013.809463

Abstract

Mucormycosis is a rare and often fatal opportunistic angioinvasive infection seen mostly in immunocompromised patients, such as those with diabetes mellitus, cancer, or renal failure. Ophthalmic manifestations of orbital mucormycosis include ocular pain, periocular oedema, visual loss, ophthalmoplegia, proptosis, and ptosis. Although therapy for orbital mucormycosis consists of maximally tolerated doses of antifungal agents (e.g., amphotericin B) and extensive surgical debridement, treatment remains ineffective in up to 20% of cases. We describe two patients with rhino-orbitalmucormycosis who were successfully treated with posaconazole in conjunction with intravenous (IV) amphotericin B and sinus surgical debridement. These cases highlight several unusual early manifestations of orbital mucormycosis, including disc oedema and amaurosis fugax, as well as the applicability of a new extended-spectrum antifungal agent in management of orbital zygomycosis.

Keywords: Disc oedema; mucormycosis; orbital apex syndrome; posaconazole; rhino-orbital

References

  1. J Korean Neurosurg Soc. 2010 Jan;47(1):74-7 - PubMed
  2. Am J Ophthalmol. 2006 Jul;142(1):187-188 - PubMed
  3. J Infect. 2007 Sep;55(3):e33-6 - PubMed
  4. Eur Arch Otorhinolaryngol. 2005 Nov;262(11):932-8 - PubMed
  5. Am J Rhinol. 2008 Jan-Feb;22(1):98-103 - PubMed
  6. J Neuroophthalmol. 1997 Mar;17(1):51-2 - PubMed
  7. Am J Ophthalmol. 2001 May;131(5):674-6 - PubMed
  8. Comput Radiol. 1984 Mar-Apr;8(2):113-7 - PubMed
  9. Pediatr Diabetes. 2009 Jun;10(4):289-93 - PubMed
  10. Curr Infect Dis Rep. 2012 Aug;14(4):423-34 - PubMed
  11. Arch Ophthalmol. 2007 Jun;125(6):848-9 - PubMed
  12. Korean J Ophthalmol. 2008 Mar;22(1):66-9 - PubMed
  13. J Laryngol Otol. 2011 Aug;125(8):807-10 - PubMed

Publication Types